 |
|
|
| |
Renal outcomes with EFV + TDF/FTC versus other TDF-containing antiretroviral regimens among HIV-infected Veterans: A national study
|
| |
| |
Reported by Jules Levin
18th International Workshop on Comorbidities and Adverse Drug Reactions in HIV, September 12-13, 2016, New York
J LaFleur,1,2 A Bress,2,3 S Esker,4 J Crook,2,5 H Nyman,1,2 R Bedimo,6,7 P Tebas,8 L Rosenblatt4
1Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA; 2Salt Lake City VA Health Care System, Salt Lake City, UT, USA; 3Division of Population Health Sciences, University of Utah, Salt Lake City, UT, USA; 4Bristol-Myers Squibb Company, Princeton, NJ, USA;
5Division of Epidemiology, University of Utah, Salt Lake City, UT, USA; 6VA North Texas Health Care System, Dallas, TX, USA; 7University of Texas Southwestern Medical Center, Dallas, TX, USA; 8Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
|
| |
|
|
|
|
|
